$ZWS

ZWS: Record Q2 growth and margins, boosted by Intellihot acquisition and raised full-year outlook

Zurn Elkay Water Solutions (ZWS) reported Q2 2026 results with 10% organic sales growth and record EBITDA margins, citing strength in Water Safety, Drinking Water, and Flow Systems. The company said its Intellihot acquisition expands its addressable market. ZWS also raised its full-year guidance for sales, EBITDA, and free cash flow, according to its Q2 2026 transcript.

Original reporting
Published Jul 29, 2026, 2:29 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 7:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ZWS: Record Q2 growth and margins, boosted by Intellihot acquisition and raised full-year outlook — source image
Decision brief

The 30-second read

$ZWSBullishMed
01

Why it matters

The key tradable element is the combination of record EBITDA margins and a raised full-year outlook across sales, EBITDA, and free cash flow, which can shift forward estimates and valuation support.

02

Market read

Guidance raise tied to margin strength and acquisition-driven expansion is likely to be the main driver for near-term positioning.

03

What to watch

The summary provides no absolute guidance numbers, cash conversion details, or integration costs, which could temper the initial enthusiasm.

Relevance 7/10Novelty 6/10Timing: after-hours or same-day reaction to Q2 results and raised full-year guidance (Jul. 29, 2026)

Background

The article is a brief transcript-style summary of Zurn Elkay Water Solutions’ Q2 2026 performance and guidance update, highlighting the Intellihot acquisition.

Company-level read

Ticker impact

$ZWSBullishMedium confidence
Context

Zurn Elkay Water Solutions reports Q2 2026 organic sales growth and record EBITDA margins, citing the Intellihot acquisition and raised full-year guidance.

Expected impact

Likely positive near-term bias as guidance lift can support estimates and sentiment, though magnitude depends on how much the raised outlook changes consensus.

Evidence & confidence

The article explicitly states record EBITDA margins, 10% organic sales growth, and that full-year sales, EBITDA, and free cash flow guidance were raised, which are direct drivers for earnings expectations.

Market effects

Strength in water safety, drinking water, and flow systems may reinforce demand expectations for plumbing and water infrastructure suppliers.

No specific regional demand or macro driver is provided in the text.

No international exposure details are included, limiting cross-market read-through.

Counterpoint

Acquisition contribution may inflate growth and margins, so investors may scrutinize whether profitability is sustainable post-integration.

Key entities

  • Zurn Elkay Water Solutions Corporation

    Subject of the article, reporting Q2 2026 organic growth, record EBITDA margins, and raised full-year guidance after the Intellihot acquisition.

  • Intellihot acquisition

    Acquisition cited as expanding the addressable market and supporting growth narrative.

Related articles

$ZWSMed

Zurn Elkay Water Solutions Cor Q2 Earnings Call Highlights

Zurn Elkay Water Solutions (NYSE: ZWS) reported Q2 call highlights, including $48M cash from IEPA and reciprocal tariff refunds, with $60M remaining uncollected. Net debt leverage ended at 0.3x. It completed the $109M Intellihot acquisition, targeting $37M sales in 2026 and raised 2026 outlook: adj. EBITDA $503M-$513M and FCF at least $350M (excluding refunds).

$ZWSMedAI 8/10

Zurn Water: Q2 Earnings Snapshot

Zurn Water Solutions (ZWS) reported Q2 profit of $113.3 million, or 67 cents per share. Adjusted earnings were 50 cents per share versus a Zacks/Wall Street estimate of 47 cents. Revenue was $491 million, above the $482.4 million expected by analysts surveyed by Zacks.

$ZWSMedAI 8/10

Zurn Elkay (NYSE:ZWS) Posts Better

Zurn Elkay (NYSE:ZWS) reported Q2 CY2026 results. Revenue rose 10.5% year on year to $491 million and exceeded Wall Street estimates by 1.6%. Non-GAAP profit was $0.50 per share, 5.8% above consensus. The company said it is raising its full-year outlook and repurchased $50 million of shares in the quarter.

$ZWSMed

Zurn Elkay Water Solutions Corp (ZWS): Results of Operations and Financial Condition

Zurn Elkay Water Solutions Corp (ZWS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991earningsrelease63026.htm EX-99.1 Document Exhibit 99.1 Press Release July 28, 2026 Contact Information: For Immediate Release Bobbi Belstner Vice President, Corporate Controller 414.361.0122 Zurn Elkay Water Solutions Reports Second Quarter 2026 Financial Results I